Cargando…

Chronic airflow obstruction in Tanzania – a cross-sectional study

BACKGROUND: Chronic obstructive pulmonary disease is a global problem and available data from sub-Saharan Africa is very limited. METHODS: A cross-sectional facility-based pilot study among patients and visitors to an urban and a rural primary healthcare facility was conducted in coastal Tanzania. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoller, Thomas, Mfinanga, Elirehema H., Zumba, Tresphory B., Asilia, Peter J., Mutabazi, Edwin M., Wimmersberger, David, Kurth, Florian, Mhimbira, Francis, Haraka, Frederick, Reither, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775540/
https://www.ncbi.nlm.nih.gov/pubmed/29351754
http://dx.doi.org/10.1186/s12890-018-0577-9
_version_ 1783293930198007808
author Zoller, Thomas
Mfinanga, Elirehema H.
Zumba, Tresphory B.
Asilia, Peter J.
Mutabazi, Edwin M.
Wimmersberger, David
Kurth, Florian
Mhimbira, Francis
Haraka, Frederick
Reither, Klaus
author_facet Zoller, Thomas
Mfinanga, Elirehema H.
Zumba, Tresphory B.
Asilia, Peter J.
Mutabazi, Edwin M.
Wimmersberger, David
Kurth, Florian
Mhimbira, Francis
Haraka, Frederick
Reither, Klaus
author_sort Zoller, Thomas
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease is a global problem and available data from sub-Saharan Africa is very limited. METHODS: A cross-sectional facility-based pilot study among patients and visitors to an urban and a rural primary healthcare facility was conducted in coastal Tanzania. The primary outcome was the prevalence of chronic airflow obstruction. RESULTS: The final analysis included 598 participants with valid post-bronchodilator spirometry. Applying ATS/ERS spirometric criteria, chronic airflow obstruction was found in n = 24 (4%, CI(95) 2.7–5.9) participants and in n = 30 (5%, CI(95) 3.5–7.1) applying GOLD spirometric criteria. To analyse risk factors for chronic airflow obstruction including those not meeting ATS/ERS or GOLD criteria, FEF(25–75) and FEV1% predicted was analysed in participants without evidence of pulmonary restriction among those exposed or not exposed to risk factors (n = 552). FEV1% predicted, but in particular FEF(25–75) decreased with increasing symptom severity of shortness of breath as well as limitations in daily activities of participants. Cooking in general and cooking with biomass fuels vs. gas or electricity was associated with significantly lower FEF(25–75), but not with lower FEV1% predicted. Participants having refrained from taking a job because of shortness of breath exhibited lower FEF(25–75) (p < 0.01). A history of prior active TB was the most relevant risk factor associated with a decrease in FEF(25–75) as well as FEV1% predicted. CONCLUSION: This study demonstrated a relevant prevalence of chronic airflow obstruction in primary healthcare attendants and healthy visitors of a Tanzanian hospital. Using the baseline data provided, larger and population-based studies are needed to validate these findings. TB may have more impact on development of chronic airway obstruction than smoking in Africa. Due to the influence of age on the GOLD definition of chronic airflow obstruction, studies should report results using both ATS/ERS and GOLD definitions and include age-stratified analysis. Analysis of FEV1 and in particular FEF(25–75) may yield additional information on risk factors and earlier stages of chronic airflow obstruction.
format Online
Article
Text
id pubmed-5775540
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57755402018-01-31 Chronic airflow obstruction in Tanzania – a cross-sectional study Zoller, Thomas Mfinanga, Elirehema H. Zumba, Tresphory B. Asilia, Peter J. Mutabazi, Edwin M. Wimmersberger, David Kurth, Florian Mhimbira, Francis Haraka, Frederick Reither, Klaus BMC Pulm Med Research Article BACKGROUND: Chronic obstructive pulmonary disease is a global problem and available data from sub-Saharan Africa is very limited. METHODS: A cross-sectional facility-based pilot study among patients and visitors to an urban and a rural primary healthcare facility was conducted in coastal Tanzania. The primary outcome was the prevalence of chronic airflow obstruction. RESULTS: The final analysis included 598 participants with valid post-bronchodilator spirometry. Applying ATS/ERS spirometric criteria, chronic airflow obstruction was found in n = 24 (4%, CI(95) 2.7–5.9) participants and in n = 30 (5%, CI(95) 3.5–7.1) applying GOLD spirometric criteria. To analyse risk factors for chronic airflow obstruction including those not meeting ATS/ERS or GOLD criteria, FEF(25–75) and FEV1% predicted was analysed in participants without evidence of pulmonary restriction among those exposed or not exposed to risk factors (n = 552). FEV1% predicted, but in particular FEF(25–75) decreased with increasing symptom severity of shortness of breath as well as limitations in daily activities of participants. Cooking in general and cooking with biomass fuels vs. gas or electricity was associated with significantly lower FEF(25–75), but not with lower FEV1% predicted. Participants having refrained from taking a job because of shortness of breath exhibited lower FEF(25–75) (p < 0.01). A history of prior active TB was the most relevant risk factor associated with a decrease in FEF(25–75) as well as FEV1% predicted. CONCLUSION: This study demonstrated a relevant prevalence of chronic airflow obstruction in primary healthcare attendants and healthy visitors of a Tanzanian hospital. Using the baseline data provided, larger and population-based studies are needed to validate these findings. TB may have more impact on development of chronic airway obstruction than smoking in Africa. Due to the influence of age on the GOLD definition of chronic airflow obstruction, studies should report results using both ATS/ERS and GOLD definitions and include age-stratified analysis. Analysis of FEV1 and in particular FEF(25–75) may yield additional information on risk factors and earlier stages of chronic airflow obstruction. BioMed Central 2018-01-19 /pmc/articles/PMC5775540/ /pubmed/29351754 http://dx.doi.org/10.1186/s12890-018-0577-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zoller, Thomas
Mfinanga, Elirehema H.
Zumba, Tresphory B.
Asilia, Peter J.
Mutabazi, Edwin M.
Wimmersberger, David
Kurth, Florian
Mhimbira, Francis
Haraka, Frederick
Reither, Klaus
Chronic airflow obstruction in Tanzania – a cross-sectional study
title Chronic airflow obstruction in Tanzania – a cross-sectional study
title_full Chronic airflow obstruction in Tanzania – a cross-sectional study
title_fullStr Chronic airflow obstruction in Tanzania – a cross-sectional study
title_full_unstemmed Chronic airflow obstruction in Tanzania – a cross-sectional study
title_short Chronic airflow obstruction in Tanzania – a cross-sectional study
title_sort chronic airflow obstruction in tanzania – a cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775540/
https://www.ncbi.nlm.nih.gov/pubmed/29351754
http://dx.doi.org/10.1186/s12890-018-0577-9
work_keys_str_mv AT zollerthomas chronicairflowobstructionintanzaniaacrosssectionalstudy
AT mfinangaelirehemah chronicairflowobstructionintanzaniaacrosssectionalstudy
AT zumbatresphoryb chronicairflowobstructionintanzaniaacrosssectionalstudy
AT asiliapeterj chronicairflowobstructionintanzaniaacrosssectionalstudy
AT mutabaziedwinm chronicairflowobstructionintanzaniaacrosssectionalstudy
AT wimmersbergerdavid chronicairflowobstructionintanzaniaacrosssectionalstudy
AT kurthflorian chronicairflowobstructionintanzaniaacrosssectionalstudy
AT mhimbirafrancis chronicairflowobstructionintanzaniaacrosssectionalstudy
AT harakafrederick chronicairflowobstructionintanzaniaacrosssectionalstudy
AT reitherklaus chronicairflowobstructionintanzaniaacrosssectionalstudy